Olgu Sunumu
BibTex RIS Kaynak Göster

Av Tam Blok Gelișen Duchenne Musküler Distrofi Tanılı Olgunun Anjiografi Laboratuvarındaki Anestezi Yönetimi

Yıl 2018, Cilt: 71 Sayı: 1, 87 - 90, 16.10.2018

Onat Bermede

Öz

Anahtar Kelimeler

Muskular Distrofi Duchenne; kalp bloğu; anestezi yönetimi

Kaynakça

  • 1. Wicki J, Seto JS, Chamberlain JS. Duchenne Muscular Dystrophy Brenner's Encyclopedia of Genetics. WA USA. 2013. p. 421e4.
  • 2. Guglieri M, Bushby K. Recent developments in the management of Duchenne muscular dystrophy. Paediatr Child Health 2011; 21(11): 501-9.
  • 3. Bartels B, Pangalila RF, Bergen MP, et al. Upper limb function in adults with Duchenne muscular dystrophy. J Rehabil Med 2011; 43(9): 770-5.
  • 4. Birnkrant DJ, Bushby KM, Amin RS, et al. The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article. Pediatr Pulmonol 2010; 45(8): 739-48.
  • 5. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170(4): 456-65.
  • 6. Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, et al. Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 2015; 7(7): 410-4.
  • 7. Obata R, Yasumi Y, Suzuki A, et al. Rhabdomyolysis in association with Duchenne’s muscular dystrophy. Can J Anesth 1999; 46(6): 564-6.
  • 8. Fayssoil A, Nardi O, Orlikowski D, et al. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev 2010; 15(1): 103-7.
  • 9. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003; 99(1): 1-19.
  • 10. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2013; 61(3): e6-75.
  • 11. Wick S, Muenster T, Schmidt J, et al. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology 2005; 102(5): 915-9.
  • 12. Birnkrat DJ, Panitch HB, Benditt JO, et al. American collage of chest physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 2007; 132(6): 1977-86.
  • 13. Girshin M, Mukherjee J, Clowney R, et al. The postoperative cardiovascular arrest of a 5-year-old male: an initial presentation of Duchenne’s muscular dystrophy. Paediatr Anaesth 2006; 16(2): 170-3.
  • 14. Shin HH, Park DH, Lee C, et al. Anesthesia for a 10-year-old boy with Duchenne muscular dystrophy syndrome: A case report. Korean J Anesthesiol 2008; 55(2): 217-20.
  • 15. Frankowski GA, Johnson JO, Tobias JD. Rapacuronium administration to two children with Duchenne’s muscular dystrophy. Anesth Analg 2000; 91(1): 27-8.
  • Kocabas S, Yedicocuklu D, Askar F, et al. Anesthetic management of a child with Duchenne muscular dystrophy undergoing correction of Fallot’s Tetralogy. Pediatric Anesthesia 2008; 18(5): 448-50.

Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory

Yıl 2018, Cilt: 71 Sayı: 1, 87 - 90, 16.10.2018

Onat Bermede

Öz

Duchenne muscular distrophy is an X-linked, recessive, inherited genetic disorder, which is seen in 1/3500 of the population and characterized by progressive muscle degeneration and contractures. As well as muscle weakness is the main problem; respiratory infections are frequent due to the difficulty of coughing and expectoration caused by the retension of respiratory muscles. Due to the cardiomyopathy, cardiac problems such as ventricular dilatation, conduction defects, supraventricular or ventricular arrhytmias, myocardial necrosis can be seen during anesthesia management. Inhalational anesthetics and depolarizing neuromuscular blocking agents may cause fatal complications such as malignant hyperthermia and rhabdomyolysis. In this article we aimed to present anesthetical management of implantation of permanent pacemaker to a patient with Duchenne Muscular Dystrophy who had a temporary transvenous pacemaker for complete atrioventricular block

Anahtar Kelimeler

anestezi Muscular Dystrophy Duchenne; Heart Block; anesthetic management

Kaynakça

  • 1. Wicki J, Seto JS, Chamberlain JS. Duchenne Muscular Dystrophy Brenner's Encyclopedia of Genetics. WA USA. 2013. p. 421e4.
  • 2. Guglieri M, Bushby K. Recent developments in the management of Duchenne muscular dystrophy. Paediatr Child Health 2011; 21(11): 501-9.
  • 3. Bartels B, Pangalila RF, Bergen MP, et al. Upper limb function in adults with Duchenne muscular dystrophy. J Rehabil Med 2011; 43(9): 770-5.
  • 4. Birnkrant DJ, Bushby KM, Amin RS, et al. The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article. Pediatr Pulmonol 2010; 45(8): 739-48.
  • 5. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170(4): 456-65.
  • 6. Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, et al. Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 2015; 7(7): 410-4.
  • 7. Obata R, Yasumi Y, Suzuki A, et al. Rhabdomyolysis in association with Duchenne’s muscular dystrophy. Can J Anesth 1999; 46(6): 564-6.
  • 8. Fayssoil A, Nardi O, Orlikowski D, et al. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev 2010; 15(1): 103-7.
  • 9. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003; 99(1): 1-19.
  • 10. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2013; 61(3): e6-75.
  • 11. Wick S, Muenster T, Schmidt J, et al. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology 2005; 102(5): 915-9.
  • 12. Birnkrat DJ, Panitch HB, Benditt JO, et al. American collage of chest physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 2007; 132(6): 1977-86.
  • 13. Girshin M, Mukherjee J, Clowney R, et al. The postoperative cardiovascular arrest of a 5-year-old male: an initial presentation of Duchenne’s muscular dystrophy. Paediatr Anaesth 2006; 16(2): 170-3.
  • 14. Shin HH, Park DH, Lee C, et al. Anesthesia for a 10-year-old boy with Duchenne muscular dystrophy syndrome: A case report. Korean J Anesthesiol 2008; 55(2): 217-20.
  • 15. Frankowski GA, Johnson JO, Tobias JD. Rapacuronium administration to two children with Duchenne’s muscular dystrophy. Anesth Analg 2000; 91(1): 27-8.
  • Kocabas S, Yedicocuklu D, Askar F, et al. Anesthetic management of a child with Duchenne muscular dystrophy undergoing correction of Fallot’s Tetralogy. Pediatric Anesthesia 2008; 18(5): 448-50.
Toplam 16 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Anesteziyoloji
Bölüm Makaleler
Yazarlar

Onat Bermede 0000-0002-8598-6264

Yayımlanma Tarihi 16 Ekim 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 71 Sayı: 1

Kaynak Göster

APA Bermede, O. (2018). Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 71(1), 87-90.
AMA Bermede O. Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory. Ankara Üniversitesi Tıp Fakültesi Mecmuası. Ekim 2018;71(1):87-90.
Chicago Bermede, Onat. “Anesthesia Management of Duchenne Muscular Dystrophy With Complete Atrioventricular Block in Angiography Laboratory”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 71, sy. 1 (Ekim 2018): 87-90.
EndNote Bermede O (01 Ekim 2018) Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory. Ankara Üniversitesi Tıp Fakültesi Mecmuası 71 1 87–90.
IEEE O. Bermede, “Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, c. 71, sy. 1, ss. 87–90, 2018.
ISNAD Bermede, Onat. “Anesthesia Management of Duchenne Muscular Dystrophy With Complete Atrioventricular Block in Angiography Laboratory”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 71/1 (Ekim 2018), 87-90.
JAMA Bermede O. Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2018;71:87–90.
MLA Bermede, Onat. “Anesthesia Management of Duchenne Muscular Dystrophy With Complete Atrioventricular Block in Angiography Laboratory”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, c. 71, sy. 1, 2018, ss. 87-90.
Vancouver Bermede O. Anesthesia Management of Duchenne Muscular Dystrophy with Complete Atrioventricular Block in Angiography Laboratory. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2018;71(1):87-90.
 Kapak Resmi İndir